The counter-regulatory effect of FGF-23 on the bone-kidney axis in chronic renal failure protects against hyperphosphatemia, vitamin D toxicity, and related soft-tissue calcifications (4, 5). This evidence concerns the gene FGF23 and chronic kidney disease.